Short Interest in PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Decreases By 21.5%

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 7,300 shares, a decline of 21.5% from the August 31st total of 9,300 shares. Based on an average daily trading volume, of 65,300 shares, the short-interest ratio is presently 0.1 days.

PreveCeutical Medical Stock Performance

PRVCF stock remained flat at $0.01 on Friday. 58,533 shares of the company traded hands, compared to its average volume of 25,857. The company has a 50-day moving average of $0.01 and a 200-day moving average of $0.02. PreveCeutical Medical has a 52 week low of $0.01 and a 52 week high of $0.02.

About PreveCeutical Medical

PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity.